CHA Biotech Co. Ltd (085660) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.043x

Based on the latest financial reports, CHA Biotech Co. Ltd (085660) has a cash flow conversion efficiency ratio of -0.043x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-35.06 Billion ≈ $-23.76 Million USD) by net assets (₩809.25 Billion ≈ $548.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

CHA Biotech Co. Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how CHA Biotech Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read CHA Biotech Co. Ltd (085660) financial obligations for a breakdown of total debt and financial obligations.

CHA Biotech Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CHA Biotech Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
TeamViewer AG F:TMV	0.803x
CureVac NV F:5CV	0.034x
O-Bank Co Ltd TW:2897	0.002x
Sichuan Jinshi Technology Co Ltd Class A SHE:002951	-0.004x
V V Food & Beverage Co Ltd SHG:600300	0.083x
CW Enerji SA IS:CWENE	-0.008x
China Petrochemical Development Corp TW:1314	-0.017x
Shanghai Kaibao Pharmaceutical SHE:300039	0.042x

Annual Cash Flow Conversion Efficiency for CHA Biotech Co. Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of CHA Biotech Co. Ltd from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see 085660 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩809.25 Billion ≈ $548.42 Million	₩-72.52 Billion ≈ $-49.15 Million	-0.090x	+48.51%
2024-12-31	₩284.69 Billion ≈ $192.93 Million	₩-49.55 Billion ≈ $-33.58 Million	-0.174x	-1092.29%
2023-12-31	₩656.33 Billion ≈ $444.79 Million	₩11.51 Billion ≈ $7.80 Million	0.018x	+124.80%
2022-12-31	₩291.73 Billion ≈ $197.70 Million	₩-20.63 Billion ≈ $-13.98 Million	-0.071x	-245.08%
2021-12-31	₩456.06 Billion ≈ $309.06 Million	₩22.23 Billion ≈ $15.06 Million	0.049x	-63.17%
2020-12-31	₩355.09 Billion ≈ $240.64 Million	₩47.00 Billion ≈ $31.85 Million	0.132x	+97.78%
2019-12-31	₩377.18 Billion ≈ $255.61 Million	₩25.24 Billion ≈ $17.10 Million	0.067x	-70.97%
2018-12-31	₩326.99 Billion ≈ $221.60 Million	₩75.38 Billion ≈ $51.09 Million	0.231x	+342.94%
2017-12-31	₩230.74 Billion ≈ $156.37 Million	₩12.01 Billion ≈ $8.14 Million	0.052x	+31.95%
2016-12-31	₩286.32 Billion ≈ $194.04 Million	₩11.29 Billion ≈ $7.65 Million	0.039x	-81.50%
2015-12-31	₩290.10 Billion ≈ $196.60 Million	₩61.86 Billion ≈ $41.92 Million	0.213x	+3732.73%
2014-12-31	₩437.45 Billion ≈ $296.46 Million	₩-2.57 Billion ≈ $-1.74 Million	-0.006x	-104.53%
2013-12-31	₩512.34 Billion ≈ $347.21 Million	₩66.35 Billion ≈ $44.97 Million	0.130x	-6.23%
2012-12-31	₩331.41 Billion ≈ $224.59 Million	₩45.77 Billion ≈ $31.02 Million	0.138x	+13.63%
2011-12-31	₩285.46 Billion ≈ $193.45 Million	₩34.69 Billion ≈ $23.51 Million	0.122x	-54.29%
2010-12-31	₩158.24 Billion ≈ $107.24 Million	₩42.07 Billion ≈ $28.51 Million	0.266x	+39.05%
2009-12-31	₩125.61 Billion ≈ $85.12 Million	₩24.02 Billion ≈ $16.28 Million	0.191x	--

About CHA Biotech Co. Ltd

KQ:085660 Korea Biotechnology

Market Cap

$885.14 Million

₩1.31 Trillion KRW

Market Cap Rank

#9659 Global

#275 in Korea

Share Price

₩17090.00

Change (1 day)

-1.78%

52-Week Range

₩9870.00 - ₩23850.00

All Time High

₩40950.00